Foad I. Abandeh, MBBS

Foad Abandeh practices at Virtua Home Care at West Jersey in Marlton, New Jersey.

Foad Abandeh's NPI, 1013215854, was assigned on March 2, 2011. Foad Abandeh holds New Jersey license 25MA11097500.

Foad Abandeh's primary practice is Virtua Home Care at West Jersey, at 301 Lippincott Drive - 2nd Floor, Marlton, NJ 08053. The practice phone is (856) 581-7200.

Foad Abandeh's primary practice is Virtua Home Care at West Jersey in Marlton, New Jersey. Foad Abandeh is also affiliated with Cooper University Hospital. The medical group on file is Virtua Medical Group. Dmand AI also links Foad Abandeh to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Foad Abandeh's employer is on file too: a home health agency.

Dmand AI tracks the electronic health record (EHR) system at each site where Foad Abandeh practices, 8 sites in all. Vendor and product names are available with a free account.

Infectious disease is Foad Abandeh's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Foad Abandeh's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 17,355 Medicare services from Foad Abandeh across 9 procedure codes in 2024, for 516 Medicare patients. Medicare paid $132,142 for them.

CMS counts 516 Medicare patients who saw Foad Abandeh in 2024. The largest group is 65 to 74, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Foad Abandeh's median patient age at 64, with 46% women.

In 2024, Foad Abandeh wrote 196 Medicare Part D claims for 49 patients. 72% of them were for generic drugs. CMS names the drug for 96 of them, across 6 drugs with 11 or more claims each, at $57,707 in total drug cost. In 2023, CMS named 67 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Foad Abandeh for performance year 2024, reported as part of a group. Foad Abandeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Foad Abandeh as offering telehealth.

Dmand AI links 5 papers to Foad Abandeh, published from 2012 to 2016. 2012 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents and Endocarditis, Bacterial. Foad Abandeh's most frequent co-authors are Jose A. Bazan, DO, Azza Abdel Hak, MD and Leslie A. Andritsos, MD.

CMS Open Payments shows 41 general payments to Foad Abandeh from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 97% of the total. Allergan Inc. paid the most, $192.